Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Return to: PBR Home | Drug Research
Today in Drug Research

Drug Research

Bristol-Myers Squibb to acquire IFM Therapeutics to expand cancer pipeline Bristol-Myers Squibb has agreed to acquire Boston-based IFM Therapeutics for an upfront payment of $300m to strengthen its oncology pipeline. Drug Research > Drug Discovery & Development > News

Latest Drug Research News by Sector

Select a sector from the list or browse by sector below:

Drug Delivery

Takeda, Cardurion Pharmaceuticals form cardiovascular development partnership
Takeda Pharmaceutical and Cardurion Pharmaceuticals have created a new cardiovascular development partnership.
Drug Research > Drug Delivery > News
Study says machine learning algorithms can help predict schizophrenia
By PBR Staff Writer
A new study has found that artificial intelligence (AI) and machine learning algorithms helped predict instances of schizophrenia with 74% accuracy.
Drug Research > Drug Delivery > News

Drug Discovery & Development

Atreca raises $35m to advance novel cancer immunotherapies
Atreca, a privately held biotechnology company developing novel therapeutics drawn from human immune responses, has closed its Series B round of financing with an investment totaling $35m.
Drug Research > Drug Discovery & Development > News
GSK to evaluate Insilico’s AI technology to enhance drug discovery process.
By PBR Staff Writer
GlaxoSmithKline and Insilico Medicine are partnering to assess how the latter’s artificial intelligence (AI) technology can help in the drug discovery process.
Drug Research > Drug Discovery & Development > News